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Abstract  
Background: Coronary artery disease is the most common cause of death in a modern world. This 
dictates the development a network of Catheterization laboratories without cardiosurgical 
capabilities. 
Aim: We postulate that the most valuable tool in the decision process on myocardial 
revascularization is fractional flow reserve (FFR), especially when we deal with borderline coronary 
lesions.  
Material and Methods: A total of 72 patients with 94 intermediate coronary stenosis (30%-70% 
diameter reduction) were included in this study. We tested FFR and angiography based decision 
model on myocardial revascularization. 
Results:  Mean FFR value on left anterior descending coronary artery (LAD) was lower than in 
others two arteries (p=0.017). FFR after percutaneous coronary intervention (PCI) was significantly 
better (p<0.0001). The decision for PCI predominates before FFR diagnostics, but after FFR the 
decision is quite opposite. There is a weak negative correlation between FFR and diameter of 
stenosis assessed by angiography (r= - 0.245 p=0.038) and positive correlation between diameter 
of stenosis assessed by angiography and by quantitative coronary angiography (QCA) (r=0.406 
p<0.0005).  
Conclusion:  Our results strongly suggest that FFR is necessary tool in centers without 
possibilities of heart team onsite consultation and that prevents numerous unnecessary PCI.  
 
 
 
 
  
Introduction 
The functional significance of coronary artery 
stenosis of intermediate severity is important in 
determining revascularization strategy in patients. By 
the early 1990s, fractional flow reserve (FFR) 
emerged as an important physiologic adjunct to 
coronary angiography for the assessment of 
intermediate lesions, directing multivessel 
percutaneous revascularization and guiding stent 
deployment. Pressure-derived fractional flow reserve 
(FFR) assessment has been extensively described 
and validated as a technique capable of identifying 
functionally significant [1, 2]. 
 
In centers without cardiosurgical capabilities, 
lack of cardiosurgeon in heart team, may cause 
subsequently inadequate decisions on myocardial 
revascularization, which make the decision process 
harder. 
 
Materials and Methods 
Study population 
Seventy two (72) patients with 94 
intermediate coronary stenosis were examined 
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between 2006 - 2009. All patients submitted to 
coronary angiography, for any reason, were eligible 
and the decision to use FFR was left entirely at the 
operator’s discretion. Patients were eligible for the 
study if they had a de novo moderate (30%-70% 
diameter) stenosis in a native coronary arteries with 
diameter >2.5 mm. Patients were excluded from the 
study if they had a history of bronchial asthma or 
bronchial hyperreactivity, severe renal failure, target 
vessel with multiple or tandem lesions, previous 
myocardial infarction in the territory of the target 
vessel. 
Table 1: Baseline characteristics. 
 
Number of patients 72 
Number of lesions 94 
Number of FFR positive lesions 26 (24.44%) 
Overall costs before FFR 94 180 € 
Overall costs after FFR 105 400 € 
Age (yrs) 58.6 + 8.57 
Male gender 71% 
A-DS (%)  53.45 + 8.80 
QCA-DS (%)  45.40 + 8.78 
FFR before PCI 80.62 + 9.89 
FFR after PCI 89.81 + 5.05 
Smoking 54% 
Hypercholesterolemia 76% 
Hypertension 82% 
Obesity 43% 
Family history of CAD 38% 
Diabetes mellitus 27% 
Acetylsalicylic acid 97% 
Clopidogrel 66% 
Beta-blockers 80% 
Calcium antagonists 51% 
Nitrates 53% 
Angiotensin-converting enzyme inhibitor 78% 
Statin 74% 
Diuretics 32% 
 
 
Assessment of the target vessel (a major 
coronary artery or major branch with visual estimated 
stenosis of >50 diameter stenosis, DS%) reference 
diameter by angiography and on-line QCA (Siemens 
Axiom Artis System) was mandatory. Quantitative 
coronary angiography was performed using the 
contrast-filled distal guiding catheter for calibration. 
The angiographic projection with the most severe 
diameter narrowing without foreshortening was used 
for analysis of stenosis severity. 
 
FFR measurements 
The ratio of the distal and the aortic pressure 
on maximal hyperemia, or pressure-derived FFR (FFR 
= Pd/Pa), has been extensively validated [3, 4].
 
 The 
stenosis was considered to be of physiologic 
significance only if the FFR was <0.75. As per 
protocol, patients were deferred from coronary 
intervention if their FFR was >0.75.  
After a diagnostic coronary angiography, 6Fr 
to 7Fr guiding catheter without side holes was used to 
engage the coronary artery. Heparin was 
administered intravenously (bolus dose of 100 U/kg). 
A 0.014-inch sensor-tipped Pressure Wire (RADI 
Medical, Uppsala, Sweden) was set at zero, 
calibrated, and advanced through the guiding 
catheter. The transducer was aligned first with the 
catheter tip to ensure that the pressure wire and 
coronary catheter recorded the same pressure, and 
then the transducer was positioned just beyond the 
stenosis. Mean coronary pressures proximal and 
distal to the stenosis were measured under maximum 
coronary hyperemia induced by administration of 
intracoronary adenosine (140 μg for the left coronary 
artery and 60 μg for the right coronary artery) after i.c. 
bolus of  nitroglycerine (200 μg for the left and 100 μg 
for the right coronary artery). Measurements were 
recorded 5 seconds after adenosine bolus. 
This was a retrospective, nonrandomized, 
observational, single-center study.  
 
Statistical considerations 
Values of examined parameters were 
analyzed using descriptive statistics, as mean and 
standard deviation. Statistical significance was 
defined at a P value of < 0.05. Comparison of two 
values of the same descriptive was done using paired 
T test. Correlation was calculated using Pearson’s 
correlation coefficient. Statistical analyses were 
performed using Statistical Package for Social 
Sciences (SPSS) statistical software (Chicago, Illinois, 
USA). 
 
Results  
In our study population, males were dominant 
(Table 1). Smoking, hypertension and hyperchole-
sterolemia were most frequent risk factors for 
coronary artery disease.  
Pretreatment with DAPT, beta blockers, ACE 
inhibitors and statins was consistent with guidelines. 
Cost of FFR diagnostic is slightly higher than without 
FFR in our institution. Values of diameter stenosis 
assessed by angiography and by QCA are in 
intermediate range. Mean FFR value is at upper limit. 
FFR value on LAD is lower than in others two arteries. 
The presumed explanation for these results lies in the 
fact that FFR is a parameter which depends of 
stenosis severity and amount of viable distal 
myocardium, and LAD has greater vascularization 
area. Stenosis on LAD was dominant (Fig. 1).  
 
Figure 1: Mean values of FFR on different coronary arteries (LAD-
LCX p=0.031; LAD-RCA p=0.017). 
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FFR after PCI is significantly better than 
before PCI, as we expected (Fig. 2).  
 
Figure 2: FFR values before and after PCI (p<0.0001). 
 
There is a weak negative correlation between 
FFR and diameter of stenosis assessed by 
angiography and positive correlation between 
diameter of stenosis assessed by angiography and by 
QCA (Table 2).  
Table 2: Correlation between different parameters. 
Correlated 
parameters 
R p Comment 
FFR-A - 0.245 0.038 Weak negative correlation 
FFR-QCA - 0.072 0.148 No correlation 
A-QCA 0.406 < 0.0005 Positive correlation 
Age-FFR 0.205 0.084 No correlation 
 
There is no correlation between other 
parameters. The decision to perform PCI 
predominates before FFR diagnostics, but after FFR 
the decision is quite opposite (Fig. 3).   
 
 
Figure 3: Decision to perform or defer (D) PCI before and after FFR. 
Discussion  
Centers without cardiosurgical capabilities 
use more efforts to indicate right therapeutical 
strategies for the patients. Among other invasive 
diagnostic modalities, like IVUS and OCT, FFR is the 
method that offers best diagnostic accuracy and 
provides reliable information on functional significance 
of coronary stenosis. This is of great importance in 
institution without cardiosurgical backup. Adequate on 
site diagnosis save time and money, compared to 
transferring patient or coronary angiogram to other 
hospital with cardiosurgeon for heart team decision 
(even then the decision is often based just on 
eyeballing). 
Most patients undergo to catheterization 
before a noninvasive evaluation [5]. In this setting, 
determining the appropriate management of an 
intermediate coronary lesion can be challenging. 
Measuring FFR has been shown by recent studies to 
be an accurate method for determining the physiologic 
significance of an intermediate coronary lesion [6-8].  
The lack of benefit of PCI on non–ischemia producing 
lesions has been clearly documented [9].
 
The recommended cut-off value for FFR is 
0.75 [10, 11] with a ‘grey zone’ between 0.75 and 
0.80.  In our routine strategy, the choice of a threshold 
is at operators discretion and location of stenosis. Just 
minority of examined lesions (24.44%) had positive 
FFR and they were treated in the same or staged 
procedure. Lowest FFR values on LAD indicate 
inaccuracy of visual assessment of borderline 
stenosis on this artery due to largest distributional 
area. Stents were successfully implanted according to 
local practice in all patients with an implantation 
pressure of 14–16 atm. The prognostic value of FFR 
after coronary stent implantation has been proved in a 
multicentre registry [12].  
In our study, FFR values after procedure are 
little lower then recommended. Possible explanation 
for these results lies in fact that many of our patients 
had diffuse atherosclerosis that may cause a graded 
continuous pressure fall over the whole arterial length 
[13]. Since we used intracoronary instead intravenous 
adenosine, we did not assess the FFR in the whole 
artery (pull back curve). In clinical follow up, we did 
not have stent thrombosis and restenosis documented 
by angiography. But, majority of our patients had a 
preserve EF% and single vessel disease. This, 
perhaps, indicate effect of more profound reactive 
hyperemia after stent deployment that decreases FFR 
values recorded immediate after PCI.  Furthermore, 
the statistical power of this study may be limited by 
the single centre approach. 
We did not found correlation between age and 
FFR. There is a weak negative correlation between 
visual assessment of diameter stenosis and FFR but 
angiography remains to be unreliable. QCA does not 
correlate with FFR and cannot be used in decision 
Simic et al. FFR in CatLab without cardiosurgery 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
OA Maced J Med Sci. 2013 Dec 15; 1(1):50-53.                                                                                                                                                                               53 
 
making process in case of borderline lesions. But, we 
found positive correlation between angiography and 
QCA evaluation of lesion severity. Explanation is that 
both methods are based on lumenography and 
morphology.
 
In our study, waste majority of stenoses are 
considered as angiography significant before FFR but 
final decision after FFR was completely different. So, 
numerous unnecessary PCI and surgical team 
consultations were avoided. Similar results were 
recently found in the group of patients with NSTEMI 
[14]. FFR measurement reduced diagnostic variability 
and changed operators’ treatment options in these 
groups of patients.  
Finally, with relatively high price of Pressure 
Wire in our country, PCI with DES penetration of 
about 25% in our hospital and accompanying therapy 
after PCI, FFR guided decisions are little more 
expensive then without FFR. This experience is 
opposite to those in other countries [15].  Possible 
explanations of these phenomenons lies in cheap 
working hours of medical stuff, poor DES penetration 
and higher prices of Pressure Wire in our country. So, 
in our local conditions, due to reimbursement 
problems, we must pay much attention on patient’s 
selection for functional diagnostics of intermediate 
coronary stenosis. We strongly recommend 
performance of exercise stress test or dobutamine 
stress echo test before FFR. But, in our opinion, FFR 
is the best additional invasive diagnostic tool in 
CathLabs without cardiosurgical backup, providing 
most valuable diagnostic information.  
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